IMNN
IMNN
NASDAQ · Biotechnology

Imunon Inc

$2.60
-0.10 (-3.70%)
As of May 16, 2:30 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +851.5% upside
Low Target $16.96
Average Target $24.74
High Target $28.19
Current Price $2.60
Current
$2.60
Target
$24.74
$16.96 $24.74 avg $28.19
Scenario Analysis
Bear Case
$16.96
552.3%
Low target
Base Case
$24.74
+851.5%
Avg target
Bull Case
$28.19
+984.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$41.22
-93.7% from high
52-Week Low
$2.50
+4.0% from low
Target vs 52W High
$24.74
-40.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%